TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 335 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $732,000 | +46.4% | 53,740 | +75.8% | 0.00% | – |
| Q3 2021 | $500,000 | -27.0% | 30,564 | -25.0% | 0.00% | – |
| Q2 2021 | $685,000 | -48.6% | 40,757 | -44.1% | 0.00% | – |
| Q1 2021 | $1,332,000 | +111.1% | 72,961 | +110.2% | 0.00% | – |
| Q4 2020 | $631,000 | -30.1% | 34,703 | -31.5% | 0.00% | – |
| Q3 2020 | $903,000 | +3.4% | 50,634 | +3.9% | 0.00% | – |
| Q2 2020 | $873,000 | +80.7% | 48,742 | +53.0% | 0.00% | – |
| Q1 2020 | $483,000 | -80.6% | 31,865 | -74.7% | 0.00% | – |
| Q4 2019 | $2,484,000 | +212.5% | 125,948 | +172.2% | 0.00% | – |
| Q3 2019 | $795,000 | +18.1% | 46,264 | +21.7% | 0.00% | – |
| Q2 2019 | $673,000 | -58.1% | 38,026 | -51.9% | 0.00% | – |
| Q1 2019 | $1,608,000 | +1.1% | 78,995 | -16.5% | 0.00% | – |
| Q4 2018 | $1,590,000 | – | 94,646 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |